# A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications

> **NCT02408523** · PHASE3 · COMPLETED · sponsor: **UCB BIOSCIENCES, Inc.** · enrollment: 242 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Lacosamide Tablet
- **DRUG:** Lasosamide Oral Solution
- **OTHER:** Placebo Tablet
- **OTHER:** Placebo Oral Solution

## Key facts

- **NCT ID:** NCT02408523
- **Lead sponsor:** UCB BIOSCIENCES, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2019-04
- **Final completion:** 2019-06
- **Target enrollment:** 242 (ACTUAL)
- **Last updated:** 2020-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02408523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02408523, "A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02408523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*